Our dermatologists assess your concerns, recommend an individualized treatment plan, and guide you through every step of the process to help you achieve healthier, more radiant-looking skin safely and confidently
Results vary, but clinical studies and real-world data show that many individuals lose 5% to 10% of their body weight by the 12-week markespecially if they reach at least the 1 mg or 1.7 mg dose by that point
Although this technology has been around the longest, it is still the best and most aggressive procedure for transforming aged and sun-damaged skin
Emellett lasstjk a gyomor kirlst, s az agy jllakottsgrt felels kzpontjaira is hatnak, ami hozzjrul a kalriabevitel cskkentshez
In the 2026 ADA Scientific Sessions, results from the Phase-3 TRANSCEND-T2D-1 study involving retatrutide, a triple agonist of GLP-1, GIP, and glucagon receptors, showed up to a 2% decrease in A1C and a 16.8% decrease in body weight over 40 weeks in patients with type 2 diabetes
Landecho MF, Tuero C, Valent V, Bilbao I, de la Higuera M, Frhbeck G